Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Corvus Pharmaceuticals, Inc.

NASDAQ: CRVS · Life Sciences · 3 alerts · CIK 1626971

Share price
$10.60Close, Nov 16
Market cap
$894M
Shares outstanding
84.35MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Corvus Pharmaceuticals, Inc. filings on SEC EDGAR ↗

5:55 PM ET Form 4
Insider Buying

Corvus Pharmaceuticals Chief Business Officer Jeffrey Arcara Buys $34.4K of Stock

Jeffrey Arcara, Chief Business Officer, bought 3,000 shares of Corvus Pharmaceuticals, Inc. at $11.46 a share, worth $34.4K in total on Nov 11, 2026. Shares held after the trade: 3,000.

Value
$34.4K
Shares
3,000
Price
$11.46
Role
Chief Business Officer
Trade date
Nov 11, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.